In the News – Los Angeles Times – Nussenzweig

New therapy keeps HIV at bay without daily drug regimen, study says   “Using antibodies against HIV could be part of a ‘kick and kill’ strategy, said study co-author Dr. Michel Nussenzweig — to kick the virus out of its … More »
Source: The Rockefeller University Newswire - Category: Biomedical Science Authors: Tags: In the News antibody therapy clinical trial HIV Michel C. Nussenzweig Michel Nussenzweig Source Type: news